AFC Gamma Declares Q4 Dividends

AFC Gamma, Inc. (NASDAQ: AFCG) announced its dividend for the quarter ending December 31, 2022.

AFC Gamma, Inc. (NASDAQ:AFCG) announced its dividend for the quarter ending December 31, 2022.

The board of directors of AFC Gamma declared a quarterly dividend of $0.56 for the quarter ending December 31, 2022 per outstanding share of common stock, payable on January 13, 2023 to the common stockholders of record on December 31, 2022. The December quarterly dividend represents a 12% year-over-year dividend increase.

About AFC Gamma, Inc.

AFC Gamma is an institutional lender that provides a range of lending solutions primarily to established operators in the cannabis industry. AFC Gamma primarily originates, structures and underwrites senior secured loans and other types of financing to operators in states that have legalized medicinal and/or adult-use cannabis. AFC Gamma’s senior management team has over 100 years of combined experience in investment management and disciplined credit investing across a range of economic cycles.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Mackenzie Marco on Unsplash

Related News

AFC Gamma Q3 Net Income Grows 45%, What About Dividend Payments?

AFC Gamma Q2 2022 Net Income Grows 147%, What About Distributable Earnings?

AFC Gamma And NewLake Capital Partners Both Increase Dividends

 

Total
0
Shares
Related Posts
Read More

FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer

AstraZeneca's breakthrough drug, Imfinzi, combined with chemotherapy, has been officially approved by the FDA to treat advanced forms of endometrial cancer with mismatch repair deficiency. This critical approval is based on Phase III trial results showing a 58% reduction in disease progression, promising improved outcomes for those battling this severe cancer.

AZN